Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun ' 23	Jun ' 22	Jun ' 21	Jun ' 20	Dec ' 18

Profit before tax

314.20

253.37

233.28

354.85

1,137.57

Net cashflow-operating activity

236.00

169.52

247.26

235.37

-130.38

Net cash used in investing activity

-21.50

-25.54

-32.27

164.64

1,269.72

Netcash used in fin. activity

-98.48

-288.63

-386.63

-883.41

-30.05

Net inc/dec in cash and equivlnt

116.02

-144.65

-171.64

-483.40

1,109.29

Cash and equivalnt begin of year

319.40

464.05

635.69

1,119.09

10.32

Cash and equivalnt end of year

435.42

319.40

464.05

635.69

1,119.61